Pathogenesis and management of pain in diabetic thin fiber neuropathy
https://doi.org/10.21518/2079-701X-2014-7-43-47
Abstract
The pathogenesis of pain in diabetic polyneuropathy, mostly with lesions of thin lightly myelinated and unmyelinated peripheral fibers, is considered. The diagnostic algorithm for the clinical form of DN and options for medication and non-medication pain management are discussed. Results of controlled clinical studies evaluating the effectiveness of different groups of drugs against neuropathic pain in diabetic neuropathy are analyzed.
About the Authors
EA Katushkina
First Moscow State Medical University named after I.M. Sechenov
Russian Federation
Russian Federation
О. OE Zinovyeva
First Moscow State Medical University named after I.M. Sechenov
Russian Federation
Russian Federation
References
1. Attal N, Cruccu G., Baron R et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. European Journal of Neurology. 2010. 17: 1113-1188.
2. Boulton AJM, Vinik AI, Arezzo JC et al. Diabetic Neuropathies. A statement by the American Diabetes Association. Diabetes Care. 2005. 28: 956-962.
3. Bril V, England J, Franklin GM et al. Evidence-based guideline: Treatment of painful diabetic neuropathy. Neurology 2011. 76: 1758-1765.
4. Cory T. Substitution of Gabapentin Therapy with Pregabalin Therapy in Neuropathic Pain due to Peripheral Neuropathy Pain Medicine. 2010. 11: 456-465.
Review
For citations:
Katushkina E, Zinovyeva O. Pathogenesis and management of pain in diabetic thin fiber neuropathy. Meditsinskiy sovet = Medical Council. 2014;(7):43-47. (In Russ.) https://doi.org/10.21518/2079-701X-2014-7-43-47
Views:
431
Email this article 